Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research symbols : SRDX save search
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
Published: 2024-01-22 (Crawled : 13:30) - biospace.com/
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -0.18%
H: 1.92%
C: -0.8%
removal
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System
Published: 2023-04-20 (Crawled : 12:00) - biospace.com/
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -1.02%
H: 2.6%
C: 1.76%
system study
Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery
Published: 2023-04-19 (Crawled : 12:00) - biospace.com/
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -0.39%
H: 4.91%
C: 2.35%
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
Published: 2022-11-17 (Crawled : 14:20) - biospace.com/
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -1.31%
H: 0.81%
C: -1.17%
trial
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
Published: 2022-11-11 (Crawled : 14:00) - biospace.com/
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -0.69%
H: 4.6%
C: 1.3%
trial
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
Published: 2022-11-02 (Crawled : 13:00) - biospace.com/
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: -0.58%
H: 2.53%
C: -0.7%
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -0.77%
H: 8.9%
C: 4.92%
conference trial transcend
Next Generation Sequencing (NGS) Market is expected to generate a revenue of USD 49.76 Billion by 2030, Globally, at 20.82% CAGR: Verified Market Research®
Published: 2022-09-16 (Crawled : 14:20) - prnewswire.com
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -0.75%
H: 7.1%
C: 2.22%
research expected market
Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases
Published: 2022-04-27 (Crawled : 12:00) - biospace.com/
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: -2.49%
H: 3.27%
C: -0.74%
system success 100
Global Hydrophilic Coating Market Size | 2022 - 2028 | Component and Application | Hit to USD 18.59 Billion By 2028: Zion Market Research
Published: 2022-03-24 (Crawled : 13:00) - prnewswire.com
TFX | $210.66 -1.76% 0.0% 290K
|
Health Technology
|
| O: 0.47%
H: 2.11%
C: 1.19%
SRDX | $26.375 -2.32% -2.37% 230K
|
Health Technology
|
| O: 0.19%
H: 1.14%
C: 1.14%
application research market
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.